Physician profile
James Azzi
NPI 1437417599
$2,889.34
in general payments reported to CMS, 2019-2025
33 companies · $555 in 2025
The $555 reported for 2025 was more than what 78% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $309 · 2021: $533 · 2022: $344 · 2023: $84.93 · 2024: $286 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $514.77 | 2021-2025 | Nuvent, Propel, Sinuva |
| Merz North America, INC. | $426.33 | 2019-2022 | |
| Stryker Corporation | $303.63 | 2019-2022 | |
| Optinose US, INC. | $241.34 | 2020-2025 | |
| Intersect Ent, INC. | $149.79 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $129.09 | 2020-2025 | Tezspire |
| Shire North American Group INC | $124.06 | 2019 | |
| Davol INC. | $102.16 | 2025 | Arista |
| Janssen Scientific Affairs, LLC | $100.00 | 2019 | |
| Glaxosmithkline, LLC. | $96.92 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $96.82 | 2021-2022 | |
| C2dx, INC | $74.87 | 2022 | |
| Acclarent, INC | $62.24 | 2020 | |
| Alk-Abello, INC | $42.08 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.96 | 2020-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $38.65 | 2022-2023 | Puraply |
| Acera Surgical, INC. | $34.29 | 2022-2024 | Restrata Wound Matrix |
| Inspire Medical Systems, INC. | $32.84 | 2024 | Inspire |
| Kerecis Limited | $30.03 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Medtronic USA, INC. | $27.84 | 2019-2020 | |
| Phadia US INC. | $26.81 | 2023 | Immunocap |
| Pharming Healthcare, INC. | $25.25 | 2023 | Ruconest |
| Merck Sharp & Dohme LLC | $22.61 | 2025 | Keytruda |
| Eyevance Pharmaceuticals LLC | $18.68 | 2021 | |
| Bioventus LLC | $17.43 | 2022 | |
| Hologic Sales and Service, LLC | $16.41 | 2023 | Coolseal Generator |
| Teva Pharmaceuticals USA, INC. | $16.18 | 2020 | |
| Aerin Medical INC. | $15.90 | 2025 | |
| Cook Medical LLC | $15.77 | 2021 | |
| Bolder Surgical LLC | $14.39 | 2021 | |
| Mimedx Group, INC. | $13.67 | 2024 | |
| Lilly USA, LLC | $12.14 | 2019 | |
| Kls-Martin L.P. | $5.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Azzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.